API SUPPLIERS

API Suppliers

28

US DMFs Filed

15

CEP/COS Certifications

JDMFs Filed

Other Certificates

Other Suppliers

API REF. PRICE (USD / KG)

3,364

API Market Place

6

INTERMEDIATES

1

DOSSIERS // FDF

USA (Orange Book)

Europe

Canada

Australia

South Africa

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS

192

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

1

News

22

REF STANDARD

EDQM

1

USP

2

JP

0

Other Listed Suppliers

2

SERVICES

0

List of Suppliers

Full Screen View

Reset Filter

Price Info

Zhejiang Xianju Pharmaceutical Co. ...

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

China

Virtual Booth

Digital Content

19-nor-4-androstene-3,17-dione

PDF Supplier PDF

URL Supplier Web Content

CAS Number

734-32-7

End Use API

Norethisterone

About The Company

With the high technology and excellent services, Xianju pharma earned a top worldwide reputation for qual...

With the high technology and excellent services, Xianju pharma earned a top worldwide reputation for quality in pharmaceutical industry. Xianju pharma has dedicated to scientific research since we were established in 1972.We developed over 100 Active Pharmaceutical Ingredients and finished formulations from then on , becoming a leader of steroids and hormones manufacturing in China. Xianju pharma has full of confidence to be a global supplier of active pharmaceutical ingredients with customized solid state specifications and unparalleled intellectual property that accomplishment our cooperation.

ASK
US

Upload
your Marketing & Sales content

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

List of Suppliers of Prestwick3_000253 intermediates listed on PharmaCompass.com

Prestwick3_000253

Prestwick3_000253

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

28 API Suppliers

15 USDMF

7 CEP/COS

3 JDMF

5 EU WC

7 NDC API

13 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

1 Suppliers

DOSSIERs // Finished Dosage Formulations

174 Dossiers

116 FDA Orange Book

19 Europe

13 Canada

2 Australia

16 South Africa

8 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL-28 - 0.05MG;1MG

TABLET;ORAL-28 - 0.35MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL-28 - 0.35MG

TABLET;ORAL-28 - 0.035MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.5MG,1MG,0.5MG

TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 0.035MG;0.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, CHEWABLE;ORAL - 0.025MG;0.8MG

RELATED EXCIPIENT COMPANIES

Suppliers

36 Kerry

17 Roquette

13 Microlex e.U

12 BASF

11 Sigachi Industries

11 Corel Pharma Chem

8 Gangwal Healthcare

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

7 Seppic

7 Gangwal Chemicals

6 Lonza Capsugel

6 Boai NKY Pharmaceuticals Ltd

6 DFE Pharma

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

5 Ideal Cures Pvt Ltd

4 Kima Chemical

4 SPI Pharma

3 Ulanqab Kema New Material

3 Pharmatrans-Sanaq

3 Ingredion Pharma Solutions

3 Prachin Chemical

3 The Dow Chemical Company

3 Vasa Pharmachem

1 Qianhao Chemical (Hebei) Co., Ltd

1 Nanjing Well Pharmaceutical

1 ACG Worldwide

1 Qualicaps

1 Shanghai Welltone Material Technology Co., Ltd

1 DKSH

1 Aeon Procare

1 Huzhou Sunflower Pharmaceutical Co. Ltd

1 Alcedo Pharmachem

EXCIPIENTS BY APPLICATIONS

73 Fillers, Diluents & Binders

44 Coating Systems & Additives

31 Direct Compression

27 Controlled & Modified Release

22 Disintegrants & Superdisintegrants

TABLET;ORAL-28 - 0.35MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL-28 - 0.035MG;1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 0.035MG;0.4MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons